Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels.
- DOI
- 10.1016/j.cancergen.2022.07.004
- Published
- 2022 Aug
- Container
- Cancer genetics
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cancergen.2022.07.004,
title = {Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels.},
author = {Sutcliffe EG and Mester JL and Susswein LR and Roberts ME and Marshall ML and Hruska KS},
year = {2022},
journal = {Cancer genetics},
doi = {10.1016/j.cancergen.2022.07.004},
url = {https://doi.org/10.1016/j.cancergen.2022.07.004}
}RIS
TY - JOUR TI - Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels. AU - Sutcliffe EG AU - Mester JL AU - Susswein LR AU - Roberts ME AU - Marshall ML AU - Hruska KS PY - 2022 JO - Cancer genetics DO - 10.1016/j.cancergen.2022.07.004 UR - https://doi.org/10.1016/j.cancergen.2022.07.004 ER -
APA
EG, S., JL, M., LR, S., ME, R., ML, M., & KS, H. (2022). Fibroblast testing can inform medical management in individuals with mosaic variants detected on hereditary cancer panels.. Cancer genetics. https://doi.org/10.1016/j.cancergen.2022.07.004
Source records
- pubmed · retrieved 2026-09-27T13:42:17.463Z
- europe-pmc · retrieved 2026-09-27T13:42:17.472Z